3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Melanoma
4
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Carcinoma, Non-Small-Cell Lung
3
Uveal Melanoma
2
Neoplasms
2
Lymphoma, Mantle-Cell
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Carcinoma, Renal Cell
2
Carcinoma
2
Breast Neoplasms
2
Waldenstrom Macroglobulinemia
1
Skin Neoplasms
1
Neoplasm Metastasis
1
Mycosis Fungoides
1
Mycoses
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, T-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lung Neoplasms
1
Interventions
aldesleukin
9
Interleukin-2
9
Nivolumab
7
fludarabine phosphate
6
Dacarbazine
6
Cyclophosphamide
6
fludarabine
5
Temozolomide
4
Ipilimumab
4
Fluorouracil
4
montanide ISA 51
3
Surveys and Questionnaires
3
Semaxinib
3
Radiotherapy
3
Radiation
3
Mohs Surgery
3
Educational Status
3
Cisplatin
3
Allovectin-7
3
zanolimumab
2
talabostat
2
sonidegib
2
poly ICLC
2
binimetinib
2
Whole-Body Irradiation
2
Vinblastine
2
Vemurafenib
2
Tacrolimus
2
Tablets
2
Surgical Procedures, Operative
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Skin Neoplasms
×
ProMune
×
Clear all
NCT00070642
2009-02-10
CPG 7909 Injection in Melanoma
Pfizer
Phase 2
Completed
184 enrolled